Logo image of GLTA

GALATA ACQUISITION CORP - A (GLTA) Stock Fundamental Analysis

NYSEARCA:GLTA - NYSE Arca - KYG3R23A1081 - Common Stock - Currency: USD

10.73  -4.07 (-27.5%)

After market: 10.4 -0.33 (-3.08%)

Fundamental Rating

1

Taking everything into account, GLTA scores 1 out of 10 in our fundamental rating. GLTA was compared to 0 industry peers in the Unkown industry. GLTA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GLTA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GLTA was profitable.
In the past year GLTA has reported a negative cash flow from operations.
GLTA Yearly Net Income VS EBIT VS OCF VS FCFGLTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

Industry RankSector Rank
ROA 0.8%
ROE 0.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GLTA Yearly ROA, ROE, ROICGLTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -0.5 -1 -1.5

1.3 Margins

GLTA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLTA Yearly Profit, Operating, Gross MarginsGLTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, GLTA has about the same amount of shares outstanding.
GLTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GLTA Yearly Shares OutstandingGLTA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M
GLTA Yearly Total Debt VS Total AssetsGLTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M

2.2 Solvency

GLTA has an Altman-Z score of 13.64. This indicates that GLTA is financially healthy and has little risk of bankruptcy at the moment.
GLTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.64
ROIC/WACCN/A
WACCN/A
GLTA Yearly LT Debt VS Equity VS FCFGLTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.05 indicates that GLTA may have some problems paying its short term obligations.
A Quick Ratio of 0.05 indicates that GLTA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
GLTA Yearly Current Assets VS Current LiabilitesGLTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

GLTA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.49%.
EPS 1Y (TTM)0.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%248.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLTA Yearly Revenue VS EstimatesGLTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
GLTA Yearly EPS VS EstimatesGLTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 153.29 indicates a quite expensive valuation of GLTA.
When comparing the Price/Earnings ratio of GLTA to the average of the S&P500 Index (29.62), we can say GLTA is valued expensively.
Industry RankSector Rank
PE 153.29
Fwd PE N/A
GLTA Price Earnings VS Forward Price EarningsGLTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLTA Per share dataGLTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GLTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GALATA ACQUISITION CORP - A

NYSEARCA:GLTA (7/10/2023, 8:04:01 PM)

After market: 10.4 -0.33 (-3.08%)

10.73

-4.07 (-27.5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.55%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap192.80M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 153.29
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)0.07
EY0.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS7.91
TBVpS7.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.8%
ROE 0.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 13.64
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%248.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-248.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.62%
OCF growth 3YN/A
OCF growth 5YN/A